Company profile for HekaBio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

HekaBio is an emerging commercial-stage biopharma and MedTech platform focused on in-licensing early, de-risked assets for Japan and the APAC region. We drive value by conducting clinical trials, securing regulatory and pricing approvals, and maximizing commercialization through our strong network of pharma, MedTech, hospitals, and government partners. With 50+ approvals in Japan and a diverse portfolio, our multicultural team...
HekaBio is an emerging commercial-stage biopharma and MedTech platform focused on in-licensing early, de-risked assets for Japan and the APAC region. We drive value by conducting clinical trials, securing regulatory and pricing approvals, and maximizing commercialization through our strong network of pharma, MedTech, hospitals, and government partners. With 50+ approvals in Japan and a diverse portfolio, our multicultural team is poised for commercial sales from Q1 2026.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Japan
Address
Address
Chikiriya Tokyo Bldg. 8F 1-9-15 Nihonbashimuromachi Chuo-ku, Tokyo 103-0022
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250615766110/en/HekaBio-Japan-based-Biopharma-and-MedTech-Platform-Enters-Strategic-Partnership-with-Alfresa-Holdings-Corporation

BUSINESSWIRE
16 Jun 2025

https://www.biospectrumasia.com/news/27/20307/limaca-medical-and-hekabio-announce-partnership.html

BIOSPECTRUMASIA
17 May 2022

https://www.biospectrumasia.com/news/26/11825/orgenesis-announces-license-agreement-with-hekabio-in-japan.html

BIOSPECTRUM
05 Oct 2018

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty